Franck Pagès
Immunology · 2005–2018
A researcher in the Science corpus: 13 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Immunology — 112 citations into it; #1,875 of 2,160 by trust here, #108 by citations
Whom Franck Pagès trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Franck Pagès overall
- Jérôme Galon
- D. Hanahan
- F. D. S. E. Melo
- Daniela Bruni
- Bernhard Mlecnik
- L. Zitvogel
- R. Weinberg
- Michael S. Rooney
- Peter David Caie
- D. Thommen
Papers from Franck Pagès's perspective
Ordered by how strongly the researchers Franck Pagès trusts endorse each paper. Same corpus, a different order for every researcher.
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
- Hallmarks of cancer: the next generation. (Cell)
- In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. (Journal of Clinical Oncology)
- American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. (Journal of Clinical Oncology)
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes (Clinical Cancer Research)
- Cancer-related inflammation (Nature)
- Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. (New England Journal of Medicine)
- Immunosuppressive networks in the tumour environment and their therapeutic relevance (Nature Reviews. Cancer)
- Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions (Nature Medicine)
Their papers
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks (2009) — 5,809 citations
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. (2018) — 1,778 citations
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability. (2016) — 930 citations
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours (2013) — 1,350 citations
- Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. (2013) — 3,752 citations
- Cancer classification using the Immunoscore: a worldwide task force (2012) — 795 citations
- The immune contexture in human tumours: impact on clinical outcome (2012) — 4,576 citations
- Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. (2011) — 988 citations
- Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. (2011) — 1,129 citations
- Immune infiltration in human tumors: a prognostic factor that should not be ignored (2010) — 1,081 citations
- In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. (2009) — 948 citations
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (2006) — 6,362 citations
- Effector memory T cells, early metastasis, and survival in colorectal cancer. (2005) — 2,124 citations